SEARCH

SEARCH BY CITATION

References

  • 1
    Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245252.
  • 2
    Henderson, R. A., Watkins, S. C. and Flynn, J. L., Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 1997. 159: 635643.
  • 3
    Iwashiro, M., Messer, R. J., Peterson, K. E., Stromnes, I. M., Sugie, T. and Hasenkrug, K. J., Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc. Natl. Acad. Sci. USA 2001. 98: 92269230.
  • 4
    McGuirk, P., McCann, C. and Mills, K. H., Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 2002. 195: 221231.
  • 5
    Bartz, H., Avalos, N. M., Baetz, A., Heeg, K. and Dalpke, A. H., Involvement of suppressors of cytokine signaling in toll-like receptor-mediated block of dendritic cell differentiation. Blood 2006. 108: 41024108.
  • 6
    Palucka, K. A., Taquet, N., Sanchez-Chapuis, F. and Gluckman, J. C., Lipopolysaccharide can block the potential of monocytes to differentiate into dendritic cells. J. Leukoc. Biol. 1999. 65: 232240.
  • 7
    Xie, J., Qian, J., Wang, S., Freeman, M. E., 3rd, Epstein, J. and Yi, Q., Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38. J. Immunol. 2003. 171: 47924800.
  • 8
    Jackson, S. H., Yu, C. R., Mahdi, R. M., Ebong, S. and Egwuagu, C. E., Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J. Immunol. 2004. 172: 23072315.
  • 9
    Cheng, F., Wang, H. W., Cuenca, A., Huang, M., Ghansah, T., Brayer, J., Kerr, W. G. et al., A critical role for Stat3 signaling in immune tolerance. Immunity 2003. 19: 425436.
  • 10
    Nefedova, Y., Cheng, P., Gilkes, D., Blaskovich, M., Beg, A. A., Sebti, S. M. and Gabrilovich, D. I., Activation of dendritic cells via inhibition of Jak2/STAT3 signaling. J. Immunol. 2005. 175: 43384346.
  • 11
    Barton, B. E., STAT3: a potential therapeutic target in dendritic cells for the induction of transplant tolerance. Expert Opin. Ther. Targets 2006. 10: 459470.
  • 12
    Geisel, J., Kahl, F., Muller, M., Wagner, H., Kirschning, C. J., Autenrieth, I. B. and Frick, J. S., IL-6 and maturation govern TLR2 and TLR4 induced TLR agonist tolerance and cross-tolerance in dendritic cells. J. Immunol. 2007. 179: 58115818.
  • 13
    Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J. and Enk, A. H., Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 1997. 159: 47724780.
  • 14
    Wakkach, A., Fournier, N., Brun, V., Breittmayer, J. P., Cottrez, F. and Groux, H., Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003. 18: 605617.
  • 15
    Adorini, L., Penna, G., Giarratana, N. and Uskokovic, M., Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J. Cell. Biochem. 2003. 88: 227233.
  • 16
    Faunce, D. E., Terajewicz, A. and Stein-Streilein, J., Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J. Immunol. 2004. 172: 19911995.
  • 17
    Menges, M., Rossner, S., Voigtlander, C., Schindler, H., Kukutsch, N. A., Bogdan, C., Erb, K. et al., Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 2002. 195: 1521.
  • 18
    Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. and Enk, A. H., Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 2000. 192: 12131222.
  • 19
    Fortsch, D., Rollinghoff, M. and Stenger, S., IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J. Immunol. 2000. 165: 978987.
  • 20
    Menetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C. and Blay, J. Y., Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 1998. 92: 47784791.
  • 21
    Mitani, H., Katayama, N., Araki, H., Ohishi, K., Kobayashi, K., Suzuki, H., Nishii, K. et al., Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells. Br. J. Haematol. 2000. 109: 288295.
  • 22
    McBride, J. M., Jung, T., de Vries, J. E. and Aversa, G., IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses. Cell. Immunol. 2002. 215: 162172.
  • 23
    Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M. et al., Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 2006. 203: 883895.
  • 24
    Okazaki, T. and Honjo, T., The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 2006. 27: 195201.
  • 25
    Brown, J. A., Dorfman, D. M., Ma, F. R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A. et al., Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 2003. 170: 12571266.
  • 26
    Yamamoto, R., Nishikori, M., Tashima, M., Sakai, T., Ichinohe, T., Takaori-Kondo, A., Ohmori, K. et al., B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma. Cancer Sci. 2009.
  • 27
    Karakhanova, S., Meisel, S., Ring, S., Mahnke, K. and Enk, A. H., ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets. Eur. J. Immunol. 2010. 40: 254266.
  • 28
    Liu, J., Hamrouni, A., Wolowiec, D., Coiteux, V., Kuliczkowski, K., Hetuin, D., Saudemont, A. et al., Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway. Blood 2007. 110: 296304.
  • 29
    Lee, S. J., Jang, B. C., Lee, S. W., Yang, Y. I., Suh, S. I., Park, Y. M., Oh, S. et al., Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274). FEBS Lett. 2006. 580: 755762.
  • 30
    Marzec, M., Zhang, Q., Goradia, A., Raghunath, P. N., Liu, X., Paessler, M., Wang, H. Y. et al., Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1). Proc. Natl. Acad. Sci. USA 2008. 105: 2085220857.
  • 31
    Thornton, A. M., Donovan, E. E., Piccirillo, C. A. and Shevach, E. M., Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J. Immunol. 2004. 172: 65196523.
  • 32
    Tokita, D., Mazariegos, G. V., Zahorchak, A. F., Chien, N., Abe, M., Raimondi, G. and Thomson, A. W., High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation 2008. 85: 369377.
  • 33
    Kawai, T. and Akira, S., TLR signaling. Cell Death Differ. 2006. 13: 816825.
  • 34
    Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. et al., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235238.
  • 35
    Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006. 24: 179189.
  • 36
    Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B. et al., Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007. 26: 371381.
  • 37
    Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K. and Sharpe, A. H., PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 2009. 206: 30153029.
  • 38
    Selenko-Gebauer, N., Majdic, O., Szekeres, A., Hofler, G., Guthann, E., Korthauer, U., Zlabinger, G. et al., B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 2003. 170: 36373644.
  • 39
    Kitamura, H., Kamon, H., Sawa, S., Park, S. J., Katunuma, N., Ishihara, K., Murakami, M. et al., IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells. Immunity 2005. 23: 491502.
  • 40
    Suh, W. K., Gajewska, B. U., Okada, H., Gronski, M. A., Bertram, E. M., Dawicki, W., Duncan, G. S. et al., The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat. Immunol. 2003. 4: 899906.
  • 41
    Sica, G. L., Choi, I. H., Zhu, G., Tamada, K., Wang, S. D., Tamura, H., Chapoval, A. I. et al., B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003. 18: 849861.
  • 42
    Collins, M., Ling, V. and Carreno, B. M., The B7 family of immune-regulatory ligands. Genome Biol. 2005. 6: 223.
  • 43
    Shen, T., Chen, X., Chen, Y., Xu, Q., Lu, F. and Liu, S., Increased PD-L1 expression and PD-L1/CD86 ratio on dendritic cells were associated with impaired dendritic cells function in HCV infection. J. Med. Virol. 82: 1152–1159.
  • 44
    Schuchmann, M., Meyer, R. G., Distler, E., von Stebut, E., Kuball, J., Schnurer, E., Wolfel, T. et al., The programmed death (PD)-1/PD-ligand 1 pathway regulates graft-versus-host-reactive CD8 T cells after liver transplantation. Am. J. Transplant. 2008. 8: 24342444.
  • 45
    Wang, W., Carper, K., Malone, F., Latchman, Y., Perkins, J., Fu, Y., Reyes, J. et al., PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection. Transplantation 2008. 86: 836844.
  • 46
    Galdiero, M., Vitiello, M., D'Isanto, M., Raieta, K. and Galdiero, E., STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6. Cytokine 2006. 36: 218228.
  • 47
    Thomson, A. W., O'Connell, P. J., Steptoe, R. J. and Lu, L., Immunobiology of liver dendritic cells. Immunol. Cell Biol. 2002. 80: 6573.
  • 48
    De Creus, A., Abe, M., Lau, A. H., Hackstein, H., Raimondi, G. and Thomson, A. W., Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J. Immunol. 2005. 174: 20372045.
  • 49
    Lunz, J. G., 3rd, Specht, S. M., Murase, N., Isse, K. and Demetris, A. J., Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity. Hepatology 2007. 46: 19461959.
  • 50
    Bosisio, D., Marazzi, I., Agresti, A., Shimizu, N., Bianchi, M. E. and Natoli, G., A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity. Embo. J. 2006. 25: 798810.
  • 51
    Bode, K. A., Schroder, K., Hume, D. A., Ravasi, T., Heeg, K., Sweet, M. J. and Dalpke, A. H., Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment. Immunology 2007. 122: 596606.